ALOPECIA AREATAPoster 7Long-Term Efficacy of Baricitinib in Alopecia Areata: 104-Week Results from BRAVE-AA1 and BRAVE-AA2 Authors: Maryanne Senna, Arash...
ALOPECIA AREATAPoster 8Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata from 2 Randomized Clinical Trials Over a Median of 1.6 Years...
ALOPECIA AREATAPoster 9Clinical Outcomes for Up-Titration with Baricitinib Therapy in Patients with Severe Alopecia Areata from BRAVE-AA1 and BRAVE-AA2 Authors:...
ALOPECIA AREATAPoster 10Baseline Distribution of Eyebrow and Eyelash Loss by Severity of Scalp Hair Loss in Phase 3 Trials of Baricitinib for Alopecia Areata...
ALOPECIA AREATAPoster 11Duration of Current Episode of Alopecia Areata (AA) Influences Prognosis During Treatment with Baricitinib in Patients with Severe AA...
ALOPECIA AREATAPoster 12Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) from the Phase 2 and Phase 3 ALLEGRO Clinical Trial...
ALOPECIA AREATAPoster 13Impact of Disease History on the Efficacy of Ritlecitinib in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3...
